CD19+CD22 CAR T-cells clinical trials

CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia

This study is testing a new cell therapy for children and young adults with a type of blood cancer called acute lymphoblastic leukaemia (ALL) that has come back. It aims to see how safe and effective these special cells are, and how long their positive effects might last.